MedTrace Logo

Detection of Pathological Lymphocytes in Patients With Autoimmune Disease

NCT02813083 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 129

Last updated 2024-04-05

No results posted yet for this study

Summary

This study will help the investigators design a method to detect the disease-causing immune cells in patients with rheumatoid arthritis (RA). Such methods are not currently available, but if successful, would help scientists to better understand the causes of RA.

Conditions

  • Arthritis, Rheumatoid

Interventions

OTHER

No intervention (observational)

No intervention (observational)

Sponsors & Collaborators

Principal Investigators

  • Daniel Mueller, M.D. · University of Minnesota

Eligibility

Min Age
18 Years
Max Age
90 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-08-31
Primary Completion
2023-09-30
Completion
2023-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02813083 on ClinicalTrials.gov